01652 福森藥業
按盘价 
1.000 +0.040 (+4.167%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -2.693% | -2.673% | 1.342% | 5.802% | 4.568% |
| 股东资金回报率 (%) | -6.161% | -5.440% | 2.527% | 10.523% | 8.301% |
| 资本运用回报率 (%) | -5.341% | -5.509% | 2.219% | 10.109% | 7.469% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 52.953% | 45.759% | 54.745% | 54.650% | 52.159% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 6.274% | 8.116% | 14.687% | 17.323% | 21.449% |
| 税前边际利润率 (%) | -5.206% | -6.303% | 6.169% | 16.104% | 15.664% |
| 纯利率 (%) | -6.414% | -7.037% | 4.316% | 14.405% | 13.116% |
變現能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 0.853 X | 0.850 X | 1.041 X | 1.206 X | 1.464 X |
| 速动比率 (X) | 0.610 X | 0.697 X | 0.792 X | 1.013 X | 1.272 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 58.160% | 54.610% | 46.992% | 46.973% | 42.057% |
| 总债项 / 总资产比率 (%) | 25.609% | 16.914% | 19.421% | 15.991% | 17.854% |
| 净债项 / 总资产比率 (%) | 23.015% | 7.426% | 12.880% | -7.938% | -10.291% |
| 总债项 / 股东资金比率 (%) | 61.065% | 37.185% | 36.569% | 30.101% | 31.183% |
| 长期债项 / 股东资金比率 (%) | 18.894% | 0.070% | 11.842% | 3.033% | 2.970% |
| 净债项 / 股东资金比率 (%) | 54.881% | 16.327% | 24.253% | -14.943% | -17.974% |
| 净现金 / (债项) ($) | (3.09亿) | (1.00亿) | (1.60亿) | 9.85千万 | 1.21亿 |
| 每股净现金 / (债项) ($) | (0.412) | (0.132) | (0.207) | 0.127 | 0.151 |
| 总债项 / 资本运用比率 (%) | 50.663% | 36.356% | 32.089% | 28.613% | 29.353% |
| 利息盈利率 (X) | N/A | N/A | 3.886 X | 9.311 X | 7.943 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 186.797日 | 159.072日 | 237.637日 | 160.209日 | 214.609日 |
| 应收贸易帐周转率日数 (日) | 138.961日 | 150.218日 | 161.606日 | 132.734日 | 130.141日 |
| 应付贸易帐周转率日数 (日) | 106.852日 | 98.617日 | 99.705日 | 66.531日 | 92.516日 |
| 备注： | 实时报价更新时间为30/08/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -36,277,000 |
| 增长率 | 4.832% |
| 每股盈利/(亏损) | RMB -0.050 |
| 每股账面资产净值 (¥) | RMB 0.751 |